6 Colo. Code Regs. § 1015-3-2-D

Current through Register Vol. 47, No. 11, June 10, 2024
Appendix 6 CCR 1015-3-2-D - FORMULARY OF MEDICATIONS ALLOWED - INTERFACILITY TRANSPORT

TABLE D.1 - CARDIOVASCULAR

Medications

EMT

EMT-IV

AEMT

EMT-I

P

Anti-arrhythmic - Amiodarone - continuous infusion

N

N

N

Y

Y

Anti-arrhythmic - Lidocaine - continuous infusion

N

N

N

Y

Y

Anticoagulant - Glycoprotein inhibitors

N

N

N

N

Y

Anticoagulant - Heparin (unfractionated)

N

N

N

N

Y

Anticoagulant - Low Molecular Weight Heparin (LMWH)

N

N

N

N

Y

Diltiazem

N

N

N

N

Y

Dobutamine

N

N

N

N

N

Dopamine - Monitoring and Maintenance

N

N

N

N

Y

Epinephrine - infusion

N

N

N

N

Y

Nicardipine

N

N

N

N

Y

Nitroglycerin, intravenous

N

N

N

N

Y

Norepinephrine

N

N

N

N

Y

Thrombolytics - Monitoring and Maintenance

N

N

N

N

Y

TABLE D.2 - HIGH RISK OBSTETRICAL PATIENTS

Medications

EMT

EMT-IV

AEMT

EMT-I

P

Magnesium sulfate

N

N

N

N

Y

Oxytocin - infusion

N

N

N

N

Y

TABLE D.3 - INTRAVENOUS SOLUTIONS

Medications

EMT

EMT-IV

AEMT

EMT-I

P

Monitoring and maintenance of hospital/medical facility initiated crystalloids

N

Y

Y

Y

Y

Monitoring and maintenance of hospital/medical facility initiated colloids (non-blood component) infusions

N

N

N

Y

Y

Monitoring and maintenance of hospital/medical facility initiated blood component infusion

N

N

N

N

Y

Initiate hospital/medical facility supplied blood component infusions

N

N

N

N

Y

Total parenteral nutrition (TPN) and/or vitamins

N

N

N

Y

Y

TABLE D.4 - MISCELLANEOUS

Medications

EMT

EMT-IV

AEMT

EMT-I

P

Antibiotic infusions

N

N

N

Y

Y

Antidote infusion - Sodium bicarbonate infusion

N

N

N

N

Y

Antiviral infusion

N

N

N

Y

Y

Electrolyte infusion - Magnesium sulfate

N

N

N

N

Y

Electrolyte infusion - Potassium chloride

N

N

N

N

Y

Insulin

N

N

N

N

Y

Mannitol

N

N

N

N

Y

Methylprednisolone - infusion

N

N

N

N

Y

Octreotide

N

N

N

N

Y

Pantoprazole

N

N

N

N

Y

6 CCR 1015-3-2-D

37 CR 12, June 25, 2014, effective 5/21/2014
37 CR 12, June 25, 2014, effective 7/15/2014
37 CR 22, November 25, 2014, effective 12/15/2014
38 CR 24, December 25, 2015, effective 1/14/2016
40 CR 10, May 25, 2017, effective 7/1/2017
40 CR 20, October 25, 2017, effective 1/1/2018
40 CR 21, November 10, 2017, effective 1/1/2018
41 CR 23, December 10, 2018, effective 1/14/2019
43 CR 22, November 25, 2020, effective 1/1/2021
44 CR 23, December 10, 2021, effective 12/30/2021
45 CR 10, May 25, 2022, effective 6/14/2022